✦ LIBER ✦

Outcomes in Diabetic and Nondiabetic Patients Treated With Everolimus- or Paclitaxel-Eluting Stents: Results From the SPIRIT IV Clinical Trial (Clinical Evaluation of the XIENCE V Everolimus Eluting Coronary Stent System)

✍ Scribed by Dean J. Kereiakes; Donald E. Cutlip; Robert J. Applegate; John Wang; Manejeh Yaqub; Poornima Sood; Xiaolu Su; Guoping Su; Naim Farhat; Ali Rizvi; Charles A. Simonton; Krishnankutty Sudhir; Gregg W. Stone

Book ID: 119270108
Publisher: Elsevier Science
Year: 2010
Tongue: English
Weight: 349 KB
Volume: 56
Category: Article
ISSN: 1558-3597
DOI: 10.1016/j.jacc.2010.10.006

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Impact of Lesion Length and Vessel Size

Impact of Lesion Length and Vessel Size on Clinical Outcomes After Percutaneous Coronary Intervention With Everolimus- Versus Paclitaxel-Eluting Stents: Pooled Analysis From the SPIRIT (Clinical Evaluation of the XIENCE V Everolimus Eluting Coronary Stent System) and COMPARE (Second-generation everolimus-eluting and paclitaxel-eluting stents in real-life practice) Randomized Trials

✍ Bimmer E. Claessen; Pieter C. Smits; Dean J. Kereiakes; Helen Parise; Martin Fah 📂 Article 📅 2011 🏛 American College of Cardiology 🌐 English ⚖ 503 KB

Performance of Everolimus-Eluting versus

Performance of Everolimus-Eluting versus Paclitaxel-Eluting Coronary Stents in Small Vessels: Results from the SPIRIT III and SPIRIT IV Clinical Trials

✍ HIROKI ITO; JAMES B. HERMILLER; MANEJEH YAQUB; WILLIAM NEWMAN; POORNIMA SOOD; JO 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 580 KB

Gender-based evaluation of the XIENCE V™

Gender-based evaluation of the XIENCE V™ everolimus-eluting coronary stent system: : Clinical and angiographic results from the spirit III randomized trial

✍ Alexandra J. Lansky; Vivian G. Ng; Halil Mutlu; Ecaterina Cristea; Julian Beneta 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 179 KB 👁 2 views

One-year outcomes of everolimus-eluting

One-year outcomes of everolimus-eluting and paclitaxel-eluting coronary stents in women: analysis from the Spirit IV Trial

✍ Alexandra J. Lansky; John Wang; Dean Kereiakes; Poornima Sood; Manejeh Yaqub; Yi 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 111 KB

Performance of everolimus-eluting and pa

Performance of everolimus-eluting and paclitaxel-eluting coronary stents in women: 2-year outcomes from the SPIRIT IV trial

✍ Alexandra J. Lansky; Manejeh Yaqub; Poornima Sood; Shi-Wa Ying; John Wang; Ronal 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 52 KB

The SPIRIT V Diabetic Study: A randomize

The SPIRIT V Diabetic Study: A randomized clinical evaluation of the XIENCE V everolimus-eluting stent vs the TAXUS Liberté paclitaxel-eluting stent in diabetic patients with de novo coronary artery lesions

✍ Eberhard Grube; Bernard Chevalier; Giulio Guagliumi; Peter C. Smits; Marrianne S 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 603 KB